Llwytho...
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer’s disease (AD), perhaps even before amyloid-β accumulation or brain atrophy. This evidence, consistent with the vascular hypothesis of AD, implicates cerebral blood fl...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Cell Mol Neurobiol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5278904/ https://ncbi.nlm.nih.gov/pubmed/26898552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10571-015-0261-z |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|